These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 9731734

  • 1. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 2. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL, Stern RS.
    J Invest Dermatol; 2005 Mar 02; 124(3):505-13. PubMed ID: 15737190
    [Abstract] [Full Text] [Related]

  • 3. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May 02; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 4. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun 02; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 5. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul 02; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL.
    N Engl J Med; 1984 May 03; 310(18):1156-61. PubMed ID: 6709010
    [Abstract] [Full Text] [Related]

  • 7. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS, Laird N.
    Cancer; 1994 Jun 01; 73(11):2759-64. PubMed ID: 8194017
    [Abstract] [Full Text] [Related]

  • 8. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr 01; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 9. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H.
    Dermatology; 1996 Apr 01; 193(3):185-91. PubMed ID: 8944338
    [Abstract] [Full Text] [Related]

  • 10. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A, Pukkala E, Koulu L, Jansén CT, Karvonen J.
    J Am Acad Dermatol; 1999 May 01; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [Abstract] [Full Text] [Related]

  • 11. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A, Hönigsmann H, Ortel B, Zussner C, Wolff K.
    J Am Acad Dermatol; 1986 Nov 01; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [Abstract] [Full Text] [Related]

  • 12. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P.
    J Invest Dermatol; 2003 Apr 01; 120(4):676-82. PubMed ID: 12648234
    [Abstract] [Full Text] [Related]

  • 13. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P.
    J Invest Dermatol; 2001 Aug 01; 117(2):365-70. PubMed ID: 11511317
    [Abstract] [Full Text] [Related]

  • 14. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE, Stern RS.
    J Invest Dermatol; 2003 Aug 01; 121(2):252-8. PubMed ID: 12880415
    [Abstract] [Full Text] [Related]

  • 15. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Aug 01; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 16. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB.
    N Engl J Med; 1979 Apr 12; 300(15):809-13. PubMed ID: 423919
    [Abstract] [Full Text] [Related]

  • 17. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ.
    J Am Acad Dermatol; 1992 Feb 12; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [Abstract] [Full Text] [Related]

  • 18. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I, Stern RS.
    Lancet; 2001 Sep 29; 358(9287):1042-5. PubMed ID: 11589933
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous carcinoma following psoralen and long-wave ultraviolet radiation (PUVA) therapy for psoriasis.
    Brown FS, Burnett JW, Robinson HM.
    J Am Acad Dermatol; 1980 May 29; 2(5):393-5. PubMed ID: 6892920
    [Abstract] [Full Text] [Related]

  • 20. Drug and chemical induced photosensitivity from a clinical perspective.
    Ibbotson S.
    Photochem Photobiol Sci; 2018 Dec 05; 17(12):1885-1903. PubMed ID: 30283959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.